Register for our free email digests:
Merck KGAA
www.emdgroup.com/en
Latest From Merck KGAA
Keytruda/Inlyta Data Stoke Competition In Kidney Cancer
Competing combination therapies may soon be battling for attention as first-line therapies for advanced or metastatic renal cell carcinoma, with Merck & Co being the latest big pharma to release more data on the Keytruda/Inlyta combo in the setting.
France's OTC Market in 2018: Self-Medication Sales Slump, Sanofi Claims Number-One Spot
Mentioned In Despatches: Ablynx's Story From The Frontline Of The Biotech Boom
A little over 12 months ago, Belgian Nanobody biotech Ablynx was at the center of a bidding war between Novo Nordisk and Sanofi. Ex-Ablynx CEO Edwin Moses talked to Scrip about the four-month period that changed the course of the company.
What Advair? GSK Plays Up Budding Oncology Pipeline In Q4 Call
GSK said its oncology pipeline has doubled in size since July to include 16 assets in the clinic and highlighted the newly in-licensed bifunctional immunotherapy M7824.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Company Type
- Midsize European
- Parent & Subsidiaries
-
Merck KGAA
- Amerpharm Investments Ltd.
- Biovation Ltd.
- Center Laboratories
- Chemische Fabrik Lehrte Dr. Andreas Kossel
- Durachemie GMBH
- E. Merck Nederland
- EM Laboratories Inc
- EM Pharmaceuticals Inc.
- EMD Biosciences Inc.
- EMD Chemicals Inc.
- EMD Lexigen Research Center
- EMD Serono Inc.
- Genpharm Inc.
- Hermal Kurt Herrmann & Co.
- Hermal Pharmaceutical Laboratories Inc.
- Laboratoire Theramex
- Laboratoires Merck-Clevenot SA
- Laboratorios BOI SA
- Lipha Chemicals Inc.
- Lipha Pharmaceuticals Inc.
- Lipha SA
- Merck Eprova AG
- Merck Ethicals
- Merck HOEI
- Merck Lipha
- Merck Pty. Ltd.
- Merck SA Industrias Quimicas
- Merck Sante SAS
- Merck Serono SA
- MilliporeSigma
- Molteni Farmaceutici
- NM Pharma AS
- Novagen Inc.
- VWR Canlab
- Senior Management
-
Stefan Oschmann, PhD, CEO
Marcus Kuhnert, CFO - Contact Info
-
Merck KGAA
Phone: (49) 6151 72 0
Frankfurter Str. 250
Darmstadt, MA 64293
Germany
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice